SPC308
Polatúsúmab vedotín
Status:
VeittApplication date:
14.7.2020Application published:
15.8.2020Grant published:
15.11.2021
Max expiry date:
14.7.2033Medicine name:
PolivyMedicine for children:
No
Timeline
Today
14.7.2020Application
15.8.2020Publication
15.11.2021Registration
14.7.2033Expires
Marketing license
IS authorization number:
EU/1/19/1388/001Date:
24.1.2020
Foreign authorization number:
EU/1/19/1388Date:
16.1.2020
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, South San Francisco, CA US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2176296